| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 27,189,000 | 24,778,000 | 29,192,000 | 32,045,000 | | Cost of Revenue | 23,446,000 | 21,662,000 | 26,653,000 | 24,999,000 | | | Gross Profit | 3,743,000 | 3,116,000 | 2,539,000 | 7,046,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,165,000 | 3,727,000 | 4,456,000 | 4,574,000 | | Non Recurring | 821,000 |
-
|
-
|
-
| | Others | (402,000) | 402,000 | 533,000 | 399,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 159,000 | (1,013,000) | (2,450,000) | 2,073,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,839,000 | 1,456,000 | (411,000) | (340,000) | | Earnings Before Interest And Taxes | 4,057,000 | 316,000 | (2,807,000) | 1,842,000 | | Interest Expense | 1,686,000 | 1,936,000 | 2,343,000 | 2,382,000 | | Income Before Tax | 2,371,000 | (1,620,000) | (5,150,000) | (540,000) | | Income Tax Expense | 25,000 | (204,000) | 874,000 | (462,000) | | Minority Interest | (101,000) |
-
| 48,000 | (51,000) | | | | Net Income From Continuing Ops | 2,245,000 | (1,416,000) | (5,976,000) | (129,000) | | | Non-recurring Events | | Discontinued Operations | 5,000 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,250,000 | (1,416,000) | (5,976,000) | (129,000) | | Preferred Stock And Other Adjustments | 11,000 | (11,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $2,261,000 | ($1,427,000) | ($5,976,000) | ($129,000) |
|
2.03% Nasdaq 0.00%
Income Statement
